- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.64 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x LWW: N-(4-(phenylsulfonyl)benzyl)-1H-pyrrolo[3,2-c]pyridine-2-carboxamide(Non-covalent)
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.2: 7 residues within 4Å:- Chain A: R.196, E.246, H.247, R.311, D.313
- Chain B: Y.18
- Ligands: PO4.14
14 PLIP interactions:11 interactions with chain A, 3 interactions with chain B- Hydrogen bonds: A:H.247, A:D.313, B:Y.18, B:Y.18
- Water bridges: A:R.196, A:R.196, A:R.196, A:H.247, A:S.248, A:R.311, B:K.400
- Salt bridges: A:R.196, A:H.247, A:R.311
PO4.3: 6 residues within 4Å:- Chain A: R.392, S.398, K.400
- Chain B: R.196
- Ligands: EDO.4, EDO.16
12 PLIP interactions:10 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:S.398, A:S.398, B:R.196
- Water bridges: A:R.392, A:R.392, A:F.399, A:K.400, A:K.415, A:K.415, B:R.196
- Salt bridges: A:R.392, A:K.400
PO4.14: 6 residues within 4Å:- Chain A: R.196
- Chain B: R.392, S.398, K.400
- Ligands: PO4.2, EDO.20
14 PLIP interactions:4 interactions with chain A, 10 interactions with chain B- Hydrogen bonds: A:R.196, B:K.415
- Water bridges: A:R.196, A:D.313, A:D.313, B:E.149, B:R.392, B:R.392, B:R.392, B:F.399, B:K.400, B:K.423
- Salt bridges: B:R.392, B:K.400
PO4.15: 6 residues within 4Å:- Chain A: Y.18
- Chain B: R.196, E.246, H.247, R.311, D.313
12 PLIP interactions:9 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:H.247
- Water bridges: B:R.196, B:R.196, B:R.196, B:S.248, B:R.311, A:K.400, A:K.400, A:K.400
- Salt bridges: B:R.196, B:H.247, B:R.311
- 19 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 7 residues within 4Å:- Chain A: R.40, R.392, D.393, N.396, C.397, S.398
- Ligands: PO4.3
Ligand excluded by PLIPEDO.5: 8 residues within 4Å:- Chain A: K.400, C.401, F.414, K.415, S.425
- Chain B: H.247, S.248, T.251
Ligand excluded by PLIPEDO.6: 7 residues within 4Å:- Chain A: E.8, F.9, N.10, L.13, A.14
- Chain B: Y.195, A.222
Ligand excluded by PLIPEDO.7: 3 residues within 4Å:- Chain A: G.383, G.384
- Chain B: R.392
Ligand excluded by PLIPEDO.8: 4 residues within 4Å:- Chain A: G.315, P.317, D.354, G.355
Ligand excluded by PLIPEDO.9: 6 residues within 4Å:- Chain A: S.31, K.32, N.136, T.137, D.138, P.139
Ligand excluded by PLIPEDO.10: 4 residues within 4Å:- Chain A: F.123, V.124, R.434, N.479
Ligand excluded by PLIPEDO.11: 3 residues within 4Å:- Chain A: Y.103, K.107, E.140
Ligand excluded by PLIPEDO.12: 4 residues within 4Å:- Chain A: I.171, I.358, N.359, Q.362
Ligand excluded by PLIPEDO.16: 7 residues within 4Å:- Chain A: R.392
- Chain B: R.311, D.313, G.353, D.354
- Ligands: PO4.3, EDO.17
Ligand excluded by PLIPEDO.17: 4 residues within 4Å:- Chain A: R.392
- Chain B: G.383, G.384
- Ligands: EDO.16
Ligand excluded by PLIPEDO.18: 5 residues within 4Å:- Chain A: K.423
- Chain B: G.315, P.317, D.354, G.355
Ligand excluded by PLIPEDO.19: 3 residues within 4Å:- Chain B: K.228, K.229, Y.231
Ligand excluded by PLIPEDO.20: 7 residues within 4Å:- Chain B: R.40, R.392, D.393, N.396, C.397, S.398
- Ligands: PO4.14
Ligand excluded by PLIPEDO.21: 7 residues within 4Å:- Chain B: K.169, E.187, V.213, N.214, F.215, K.216, R.477
Ligand excluded by PLIPEDO.22: 8 residues within 4Å:- Chain A: H.247, S.248, T.251
- Chain B: K.400, C.401, F.414, K.415, S.425
Ligand excluded by PLIPEDO.23: 6 residues within 4Å:- Chain B: S.31, K.32, N.136, T.137, D.138, P.139
Ligand excluded by PLIPEDO.24: 7 residues within 4Å:- Chain A: Y.195, A.222
- Chain B: E.8, F.9, N.10, L.13, A.14
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain B: S.180, G.181, N.182, S.338, K.339
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zheng, X. et al., Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors. Bioorg.Med.Chem.Lett. (2014)
- Release Date
- 2013-12-25
- Peptides
- Nicotinamide phosphoribosyltransferase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.64 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x LWW: N-(4-(phenylsulfonyl)benzyl)-1H-pyrrolo[3,2-c]pyridine-2-carboxamide(Non-covalent)
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
- 19 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zheng, X. et al., Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors. Bioorg.Med.Chem.Lett. (2014)
- Release Date
- 2013-12-25
- Peptides
- Nicotinamide phosphoribosyltransferase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B